HHS-OASH-2026-0397 | RFI Q2, Q3, Q5, Q7–13, Q15–18 Questions for HHS: What remains uncertain about chroni…

HHS public comment #6960 · HHS-OASH-2026-0397 · 2026-10-28

#1HHS-OASH-2026-0397 | RFI Q2, Q3, Q5, Q7–13, Q15–18 Questions for HHS: What remains uncertain about chroni…by Andrew Mills » 2026-10-28
Original comment · unedited text

HHS-OASH-2026-0397 | RFI Q2, Q3, Q5, Q7–13, Q15–18

Questions for HHS: What remains uncertain about chronic, multi-source RF/EMF exposure? How can studies test reported sensitivity and possible oxygen-handling effects? What exposure information and practical options should be available in homes, schools, workplaces and vehicles?

I respond as an individual consumer and family member in the UK, not as a clinician or scientist. My attachment, Where Can They Hide?, provides sources. [P] means peer-reviewed research, [G] official/legal material and [L] lived experience.

Imagine a grandchild asking what we did when people reported illness in wireless environments. I cannot say RF/EMF is established as the cause. I ask HHS to listen without prejudging, measure exposure better and fund independent research.

Experiences (Q3) [L]. I associate neurological and mood changes with RF/EMF exposure, particularly disproportionate anger or irritability, including while driving. Family and friends report different symptoms they associate with exposure: neurological problems, severe skin inflammation sometimes cracking or bleeding, eye pain and cardiac symptoms. Some report improvement after suspected sources, including Wi-Fi, were switched off. Friends said their six-week-old baby slept through for the first time after both parents switched off phones and Wi-Fi overnight; a family member reported similar sleep improvement. These uncontrolled reports do not prove causation: exposure was not measured, several sources changed together and other explanations remain possible.

Evidence and uncertainty (Q5, Q6, Q12, Q16) [P/G]. RF heating is established and central to current limits. ICNIRP’s 2020 guidelines reflect the mainstream view that heating is the only substantiated adverse effect in its assessment; this deserves fair consideration. Yet chronic, multi-source exposure and individual responses should be tested. The 2021 Environmental Health Trust v FCC ruling required the FCC to address issues it had not adequately explained; it did not find limits unsafe or decide the science. Controlled human provocation reviews have not established a consistent RF trigger for reported symptoms, but individual-level questions remain.

Oxygen handling (Q12, Q16) [P/O]. Laboratory studies report changes in haemoglobin oxygen affinity or deoxygenation under particular conditions (Mousavy, 2009; Muehsam, 2013; Chowdhury, 2021). A small 2025 wearable study reported differences in estimated overnight oxygen saturation with and without a nearby phone. Neither proves that everyday RF lowers arterial oxygen saturation or causes tissue hypoxia; these endpoints need independent replication. Redmayne’s 2022 newsletter case reported a teenager’s skin improving after Ginkgo biloba, but measured neither RF exposure nor oxygenation. These observations raise a question, not a conclusion.

Priorities (Q7–13, 15–18): (1) Fund preregistered studies co-designed with people reporting sensitivity, using verified exposure/sham conditions, blinding, clinical assessment and independent replication. (2) Test whether frequency, modulation, intensity and duration affect haemoglobin, red-cell function, arterial oxygen saturation or tissue oxygen delivery, distinguishing altered oxygen unloading from oxygen deficiency. (3) Improve real-world personal measurement, including pregnancy/childhood and homes, schools, workplaces, transport and vehicles; record source, frequency, modulation, duty cycle, distance and cumulative exposure; assess environmental/livestock exposure where relevant (Q14–15). (4) Develop privacy-protecting adverse-event/cluster reporting (Q10); publish accessible exposure information (Q9); evaluate wired alternatives and non-essential vehicle transmitter controls that preserve safety (Q13). (5) Transparently compare FCC, ICNIRP, IEEE and other frameworks, coordinate NIH research, CDC surveillance and FDA device testing/information (Q5, Q17), declare conflicts and report positive and null findings.

In EAM v East Sussex County Council [2022] UKUT 193 (AAC), the Upper Tribunal ordered educational provision, including wired internet, for a child whose reported sensitivity was accepted as disabling in that case. This is not a general scientific finding that RF causes EHS or binding on US agencies; it illustrates practical accommodation issues while causation remains contested. Judgment

What measurements could detect a reproducible effect? What fair studies would resolve uncertainty? What practical options can be offered while research proceeds?

When that grandchild asks what we did, I hope we can say we neither presumed danger nor assumed every question was settled. We listened, measured, tested competing explanations and reported findings openly. I ask HHS to make that effort.

Attachments · 4

Preview: Where Can They Hide v2

If the preview is blank, open the PDF in a new tab.

Original public attachments as filed. Their contents are not included in the topic review.

Share this public comment

Share guide: link to the comment page, quote the commenter's own words, and point people to the official docket to file their own comment.

Discuss this comment

Replies are reviewed before they appear. This is a community discussion, not an official HHS filing.

Replies